Peripheral group 2 innate lymphoid cells are decreased following nasal allergen challenge in allergic rhinitis von Tenn, Mark W., Thiele, Jenny, Steacy, Lisa M., Adams, Daniel E., Ellis, Anne K.

Volltext

Relationship Between Complete Blood Counts with Differentials and Nasal Symptoms in the Environmental Exposure Unit versus the Nasal Allergen Challenge Model von Tenn, Mark W., BHSc, Steacy, Lisa M., BSc, Thiele, Jenny, MSc, Adams, Daniel E., BSc, Walker, Terry J., BA, Ellis, Anne K., MD, FAAAAI

Volltext

Onset of action for loratadine tablets for the symptomatic control of seasonal allergic rhinitis in adults challenged with ragweed pollen in the Environmental Exposure Unit: a post... von Tenn, Mark W, Steacy, Lisa M, Ng, Charlene C, Ellis, Anne K

Volltext

Advances in rhinitis: Models and mechanisms von Ellis, Anne K, Tenn, Mark W

Volltext

Persistence of the clinical effect of grass allergen peptide immunotherapy after the second and third grass pollen seasons von Ellis, Anne K., Frankish, Charles W., Armstrong, Kristen, Steacy, Lisa, Tenn, Mark W., Pawsey, Stephen, Hafner, Roderick P.

Volltext

Nasal challenges in allergen immunotherapy trials von Tenn, Mark W, Rawls, Matthew, Ellis, Anne K

Volltext

Lack of effect of Timothy grass pollen sublingual immunotherapy tablet on birch pollen–induced allergic rhinoconjunctivitis in an environmental exposure unit von Ellis, Anne K., Tenn, Mark W., Steacy, Lisa M., Adams, Daniel E., Day, Andrew G., Walker, Terry J., Nolte, Hendrik

Volltext

The clinical relevance of filaggrin mutations: Effect on allergic disease von Tenn, Mark W, Ellis, Anne K

Volltext

Comparison of allergic rhinitis outcomes of the environmental exposure unit and nasal allergen challenge model von Tenn, Mark W., Steacy, Lisa M., Adams, Daniel E., Walker, Terry J., Ellis, Anne K.

Volltext

Clinical standardization of two controlled allergen challenge facilities: The Environmental Exposure Unit and the Biogenics Research Chamber von Ellis, Anne K, Jacobs, Robert L, Tenn, Mark W, Steacy, Lisa M, Adams, Daniel E, Walker, Terry J, Togias, Alkis, Ramirez, Daniel A, Andrews, Charles P, Visness, Cynthia M, James, Robert L, Rather, Cynthia G

Volltext

The clinical relevance of filaggrin mutations von Tenn, Mark W., BHSc, Ellis, Anne K., MD, MSc, FRCPC

Volltext

Mechanism of Synthetic Peptide Immuno-Regulatory Epitopes and Their Clinical Efficacy in the Treatment of Allergic Disease von Tenn, Mark W., Ellis, Anne K.

Volltext

Advances in rhinitis von Ellis, Anne K., Tenn, Mark W.

Volltext

Clinical standardization of two controlled allergen challenge facilities von Ellis, Anne K., Jacobs, Robert L., Tenn, Mark W., Steacy, Lisa M., Adams, Daniel E., Walker, Terry J., Togias, Alkis, Ramirez, Daniel A., Andrews, Charles P., Visness, Cynthia M., James, Robert L., Rather, Cynthia G.

Volltext

AllerGen’s 8th research conference von Arrieta, Marie-Claire, Arevalos, Andrea, Stiemsma, Leah, Chico, Marta E., Sandoval, Carlos, Jin, Minglian, Walter, Jens, Cooper, Phil, Finlay, Brett, Bernatchez, Emilie, Gold, Matthew J., Langlois, Anick, Blais-Lecours, Pascale, Duchaine, Caroline, Marsolais, David, McNagny, Kelly M., Blanchet, Marie-Renée, Brubacher, Jordan, Chhetri, Bimal, Sabaliauskas, Kelly, Bassil, Kate, Kwong, Jeff, Coates, Frances, Takaro, Tim K., Chow, Angela, Miller, Gregory E., Chen, Edith, Mandhane, Piushkumar J., Turvey, Stuart E., Elliott, Susan J., Becker, Allan B., Subbarao, Padmaja, Sears, Malcolm R., Kozyrskyj, Anita L., Dubeau, Aimée, Lu, Zihang, Balkovec, Susan, Kowalik, Krzysztof, Gustafsson, Per, Ratjen, Felix, Edgar, Rachel D., Bush, Nicole R., MacIssac, Julie L., McEwen, Lisa M., Boyce, Thomas W., Kobor, Michael S., Emmerson, Melanie, Shen, Bingqing, Moraes, Theo J., Gabrielli, Sofianne, Clarke, Ann, Eisman, Harley, Morris, Judy, Joseph, Lawrence, LaVieille, Sebastien, Ben-Shoshan, Moshe, Islam, Sumaiya A., Brückmann, Christof, Nieratschker, Vanessa, Jamieson, Kyla C., Proud, David, Kanagaratham, Cynthia, Camateros, Pierre, Kopriva, Frantisek, Henri, Jennifer, Hajduch, Marian, Radzioch, Danuta, Kang, Liane J., Koleva, Petya T., Field, Catherine J., Konya, Tedd, Scott, James A., Konya, Theodore, Azad, Meghan B., Brook, Jeff, Guttman, David, Kumari, Manjeet, Bridgman, Sarah L., Tun, Mon H., Mandal, Rupasri, Wishart, David S., Lee, Amy H. Y., Xia, Jeff, Gill, Erin, Hancock, Bob, Maestre, Danay, Sutherland, Darren, Hirota, Jeremy, Pena, Olga, Carlsten, Christopher, Jones, Meaghan J., MacIsaac, Julia L., Dow, William H., Rosero-Bixby, Luis, Rehkopf, David H., Morimoto, Takeshi, Smith, Steven G., Oliveria, John-Paul, Beaudin, Suzanne, Schlatman, Abbey

Volltext

Discovery and Preclinical Pharmacology of NX-2127, an Orally Bioavailable Degrader of Bruton’s Tyrosine Kinase with Immunomodulatory Activity for the Treatment of Patients with B C... von Robbins, Daniel W., Noviski, Mark A., Tan, Ying Siow, Konst, Zef A., Kelly, Aileen, Auger, Paul, Brathaban, Nivetha, Cass, Robert, Chan, Ming Liang, Cherala, Ganesh, Clifton, Matthew C., Gajewski, Stefan, Ingallinera, Timothy G., Karr, Dane, Kato, Daisuke, Ma, Jun, McKinnell, Jenny, McIntosh, Joel, Mihalic, Jeff, Murphy, Brent, Panga, Jaipal Reddy, Peng, Ge, Powers, Janine, Perez, Luz, Rountree, Ryan, Tenn-McClellan, Austin, Sands, Arthur T., Weiss, Dahlia R., Wu, Jeffrey, Ye, Jordan, Guiducci, Cristiana, Hansen, Gwenn, Cohen, Frederick

Volltext

NRX-0492 degrades wild-type and C481 mutant BTK and demonstrates in vivo activity in CLL patient-derived xenografts von Zhang, Deyi, Harris, Hailey M., Chen, Jonathan, Judy, Jen, James, Gabriella, Kelly, Aileen, McIntosh, Joel, Tenn-McClellan, Austin, Ambing, Eileen, Tan, Ying Siow, Lu, Hao, Gajewski, Stefan, Clifton, Matthew C., Yung, Stephanie, Robbins, Daniel W., Pirooznia, Mehdi, Skånland, Sigrid S., Gaglione, Erika, Mhibik, Maissa, Underbayev, Chingiz, Ahn, Inhye E., Sun, Clare, Herman, Sarah E. M., Noviski, Mark, Wiestner, Adrian

Volltext

Nx-5948, a Selective Degrader of BTK with Activity in Preclinical Models of Hematologic and Brain Malignancies von Robbins, Daniel W, Noviski, Mark, Rountree, Ryan, Tan, May, Brathaban, Nivetha, Ingallinera, Timothy, Karr, Dane E, Kelly, Aileen, Konst, Zef, Ma, Jun, Tenn-McClellan, Austin, McKinnell, Jenny, Perez, Luz, Guiducci, Cristiana, Hansen, Gwenn, Sands, Arthur

Volltext

Targeted Protein Degradation of BTK As a Unique Therapeutic Approach for B Cell Malignancies von Kelly, Aileen, Robbins, Daniel W, Tan, May, Tenn-McClellan, Austin, McIntosh, Joel, Wu, Jeffrey, Konst, Zef, Kato, Daisuke, Perez, Luz, Tung, Jennifer, Kolobova, Anna, Ingallinera, Timothy, McKinnell, Jenny, Weiss, Dahlia, Noviski, Mark, Ye, Jordan, Peng, Ge, Cardozo, Mario, Mihalic, Jeff, Basham, Steve, Rountree, Ryan, Karr, Dane E, Bence, Neil, Zapf, Christoph W, Sands, Arthur T

Volltext

Nx-2127, a Degrader of BTK and IMiD Neosubstrates, for the Treatment of B-Cell Malignancies von Robbins, Daniel W, Kelly, Aileen, Tan, May, McIntosh, Joel, Wu, Jeffrey, Konst, Zef, Kato, Daisuke, Peng, Ge, Mihalic, Jeff, Weiss, Dahlia, Perez, Luz, Tung, Jennifer, Kolobova, Anna, Borodovsky, Sasha, Rountree, Ryan, Tenn-McClellan, Austin, Noviski, Mark, Ye, Jordan, Basham, Steve, Ingallinera, Timothy, McKinnell, Jenny, Karr, Dane E, Powers, Janine, Guiducci, Cristiana, Sands, Arthur

Volltext